FOLH1 and neoplasm: In a LNCaP xenograft model, 24 h after intravenous injection [89Zr]Zr-PSMA-DFO showed a higher tumor-to-background ratio than [68Ga]Ga-PSMA-11 and [18F]JK-PSMA-7 after 2 and 4 h.